165 related articles for article (PubMed ID: 26654842)
1. Discontinuation of enzyme replacement therapy in Fabry disease in the Dutch cohort.
Arends M; Linthorst GE; Hollak CE; Biegstraaten M
Mol Genet Metab; 2016 Feb; 117(2):194-8. PubMed ID: 26654842
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document.
Biegstraaten M; Arngrímsson R; Barbey F; Boks L; Cecchi F; Deegan PB; Feldt-Rasmussen U; Geberhiwot T; Germain DP; Hendriksz C; Hughes DA; Kantola I; Karabul N; Lavery C; Linthorst GE; Mehta A; van de Mheen E; Oliveira JP; Parini R; Ramaswami U; Rudnicki M; Serra A; Sommer C; Sunder-Plassmann G; Svarstad E; Sweeb A; Terryn W; Tylki-Szymanska A; Tøndel C; Vujkovac B; Weidemann F; Wijburg FA; Woolfson P; Hollak CE
Orphanet J Rare Dis; 2015 Mar; 10():36. PubMed ID: 25885911
[TBL] [Abstract][Full Text] [Related]
3. Enzyme replacement therapy stabilized white matter lesion progression in Fabry disease.
Fellgiebel A; Gartenschläger M; Wildberger K; Scheurich A; Desnick RJ; Sims K
Cerebrovasc Dis; 2014; 38(6):448-56. PubMed ID: 25502511
[TBL] [Abstract][Full Text] [Related]
4. Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry Disease.
Nowak A; Koch G; Huynh-Do U; Siegenthaler M; Marti HP; Pfister M
Kidney Blood Press Res; 2017; 42(1):1-15. PubMed ID: 28253518
[TBL] [Abstract][Full Text] [Related]
5. Kidney function and 24-hour proteinuria in patients with Fabry disease during 36 months of agalsidase alfa enzyme replacement therapy: a Brazilian experience.
Thofehrn S; Netto C; Cecchin C; Burin M; Matte U; Brustolin S; Nunes AC; Coelho J; Tsao M; Jardim L; Giugliani R; Barros EJ
Ren Fail; 2009; 31(9):773-8. PubMed ID: 19925283
[TBL] [Abstract][Full Text] [Related]
6. Gender Differences in the Application of Spanish Criteria for Initiation of Enzyme Replacement Therapy for Fabry Disease in the Fabry Outcome Survey.
Barba-Romero MÁ; Pintos-Morell G
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27886142
[TBL] [Abstract][Full Text] [Related]
7. [Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature].
Riccio E; Capuano I; Visciano B; Marchetiello C; Petrillo F; Pisani A
G Ital Nefrol; 2013; 30(5):. PubMed ID: 24402625
[TBL] [Abstract][Full Text] [Related]
8. Hearing loss in adult patients with Fabry disease treated with enzyme replacement therapy.
Suntjens EB; Smid BE; Biegstraaten M; Dreschler WA; Hollak CE; Linthorst GE
J Inherit Metab Dis; 2015 Mar; 38(2):351-8. PubMed ID: 25395255
[TBL] [Abstract][Full Text] [Related]
9. Unravelling the mechanism of action of enzyme replacement therapy in Fabry disease.
Ko Y; Lee C; Moon MH; Hong GR; Cheon CK; Lee JS
J Hum Genet; 2016 Feb; 61(2):143-9. PubMed ID: 26490183
[TBL] [Abstract][Full Text] [Related]
10. Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry disease.
Lenders M; Oder D; Nowak A; Canaan-Kühl S; Arash-Kaps L; Drechsler C; Schmitz B; Nordbeck P; Hennermann JB; Kampmann C; Reuter S; Brand SM; Wanner C; Brand E
J Intern Med; 2017 Sep; 282(3):241-253. PubMed ID: 28682471
[TBL] [Abstract][Full Text] [Related]
11. Multicenter Female Fabry Study (MFFS) - clinical survey on current treatment of females with Fabry disease.
Lenders M; Hennermann JB; Kurschat C; Rolfs A; Canaan-Kühl S; Sommer C; Üçeyler N; Kampmann C; Karabul N; Giese AK; Duning T; Stypmann J; Krämer J; Weidemann F; Brand SM; Wanner C; Brand E
Orphanet J Rare Dis; 2016 Jun; 11(1):88. PubMed ID: 27356758
[TBL] [Abstract][Full Text] [Related]
12. Enzyme replacement therapy in two Japanese siblings with Fabry disease, and its effectiveness on angiokeratoma and neuropathic pain.
Furujo M; Kubo T; Kobayashi M; Ohashi T
Mol Genet Metab; 2013 Nov; 110(3):405-10. PubMed ID: 23906479
[TBL] [Abstract][Full Text] [Related]
13. Favourable effect of early versus late start of enzyme replacement therapy on plasma globotriaosylsphingosine levels in men with classical Fabry disease.
Arends M; Wijburg FA; Wanner C; Vaz FM; van Kuilenburg ABP; Hughes DA; Biegstraaten M; Mehta A; Hollak CEM; Langeveld M
Mol Genet Metab; 2017 Jun; 121(2):157-161. PubMed ID: 28495078
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of patients treated through the Canadian Fabry disease initiative.
Sirrs SM; Bichet DG; Casey R; Clarke JT; Lemoine K; Doucette S; West ML;
Mol Genet Metab; 2014 Apr; 111(4):499-506. PubMed ID: 24534763
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of tissue Doppler on early detection of cardiac disease in Fabry patients and potential role of enzyme replacement therapy (ERT) for avoiding progression of disease.
Zamorano J; Serra V; Pérez de Isla L; Feltes G; Calli A; Barbado FJ; Torras J; Hernandez S; Herrera J; Herrero JA; Pintos G
Eur J Echocardiogr; 2011 Sep; 12(9):671-7. PubMed ID: 21810826
[TBL] [Abstract][Full Text] [Related]
16. Agalsidase alfa in pediatric patients with Fabry disease: a 6.5-year open-label follow-up study.
Schiffmann R; Pastores GM; Lien YH; Castaneda V; Chang P; Martin R; Wijatyk A
Orphanet J Rare Dis; 2014 Nov; 9():169. PubMed ID: 25425121
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of enzyme replacement therapy for Fabry disease.
Rombach SM; Hollak CE; Linthorst GE; Dijkgraaf MG
Orphanet J Rare Dis; 2013 Feb; 8():29. PubMed ID: 23421808
[TBL] [Abstract][Full Text] [Related]
18. [The switch of enzyme therapy in Fabry disease].
Riccio E; Pisani A
G Ital Nefrol; 2014; 31(4):. PubMed ID: 25098458
[TBL] [Abstract][Full Text] [Related]
19. [Clinical efficacy of enzyme replacement therapy in Fabry disease. A critical review].
Lidove O; Papo T
Rev Med Interne; 2009 Oct; 30(10):920-9. PubMed ID: 19524334
[TBL] [Abstract][Full Text] [Related]
20. Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy.
Mignani R; Feriozzi S; Pisani A; Cioni A; Comotti C; Cossu M; Foschi A; Giudicissi A; Gotti E; Lozupone VA; Marchini F; Martinelli F; Bianco F; Panichi V; Procaccini DA; Ragazzoni E; Serra A; Soliani F; Spinelli L; Torti G; Veroux M; Cianciaruso B; Cagnoli L
Nephrol Dial Transplant; 2008 May; 23(5):1628-35. PubMed ID: 18057066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
